Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
9.06
2.36 (35.22%)
At close: Jun 16, 2025, 3:59 PM
8.97
-0.99%
Pre-market: Jun 17, 2025, 04:00 AM EDT
35.22% (1D)
| Bid | 8.97 |
| Market Cap | 567.34M |
| Revenue (ttm) | 47.4M |
| Net Income (ttm) | -354.4M |
| EPS (ttm) | -5.8 |
| PE Ratio (ttm) | -1.56 |
| Forward PE | -2.42 |
| Analyst | Hold |
| Ask | 9.1 |
| Volume | 26,390,560 |
| Avg. Volume (20D) | 969,142 |
| Open | 9.08 |
| Previous Close | 6.70 |
| Day's Range | 8.96 - 9.15 |
| 52-Week Range | 4.62 - 13.47 |
| Beta | 0.17 |
About SAGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SAGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SAGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 day ago
+35.37%
Sage Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
5 months ago
+35.14%
Sage Therapeutics shares are trading higher after the company confirmed the receipt of an unsolicited, nonbinding proposal from Biogen to acquire all outstanding shares not already owned by Biogen for $7.22 per share.
